C. Smith

发表

Synthesis and Biological Evaluation of 14‐Alkoxymorphinans, V1): 6‐Deoxocyprodime, an Opioid Antagonist with Decreased μ Receptor Selectivity in Comparison to Cyprodime

H. Schmidhammer, H. K. Jennewein, C. Smith, 1991, Archiv der Pharmazie.

Structure‐activity relationships of methionine‐enkephalin

B. Morgan, J. Hughes, H. Kosterlitz, 1976, The Journal of pharmacy and pharmacology.

Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.

A. Roach, C. Smith, J. Doxey, 1983, British journal of pharmacology.

Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity.

A. Roach, C. Chapleo, M. Stillings, 1984, Journal of medicinal chemistry.

Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.

A. Roach, C. Smith, J. Doxey, 1992, European journal of pharmacology.

N-Methylnalorphine: definition of N-allyl conformation for antagonism at the opiate receptor.

O. Kennard, L. P. Wakelin, R. Kobylecki, 1982, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of some 6 beta-acrylamido penicillins.

J. Davies, T. Grinter, R. Ponsford, 1993, Journal of antibiotics (Tokyo. 1968).

alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants.

A. Roach, C. Chapleo, P. Myers, 1983, Journal of medicinal chemistry.

Improved synthesis of pentabromophenylmagnesium bromide and 1,2,4,5-tetrabromophenylbis(magnesium bromide)

C. Tamborski, G. J. Moore, C. Smith, 1971 .

Indoline analogues of idazoxan: potent alpha 2-antagonists and alpha 1-agonists.

A. Roach, C. Chapleo, M. Stillings, 1988, Journal of medicinal chemistry.

Synthesis and reactions of some pentabromophenyl organometallics

C. Tamborski, G. J. Moore, C. Smith, 1972 .

Heteroaromatic analogues of the alpha 2-adrenoreceptor partial agonist clonidine.

A. Roach, C. Chapleo, M. Stillings, 1989, Journal of medicinal chemistry.

Perkin communications. Stereochemistry of substituted 1-alkoxybicyclo[2.2.2]octenes; Diels–Alder synthesis versus Tandem-Michael strategy

J. Bateson, C. Smith, J. Wilkinson, 1991 .

HIGH-MOLECULAR-WEIGHT HYDROCARBONS AND HYDROCARBON INTERMEDIATES. II

C. Smith, E. Lieber, L. A. Mikeska, 1938 .

Synthesis of fused furans by gas-phase pyrolysis of2-allyloxyarylpropenoic esters1

H. Mcnab, J. Cadogan, M. Black, 1997 .

Synthesis of Fused Furans by Gas-Phase Pyrolysis of 2- Allyloxyarylpropenoic Esters.

H. Mcnab, J. Cadogan, M. Black, 1997 .

Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

B. Morgan, C. Smith, B. Handa, 1981, European journal of pharmacology.

Opioid receptors in the mouse ileum.

C. Smith, C. Waldron, N. A. Brook, 1988, Archives internationales de pharmacodynamie et de therapie.

Morphine, but not diacetyl morphine (heroin), possesses opiate antagonist activity in the mouse vas deferens

C. Smith, 1984, Neuropeptides.

Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist.

W. Burkard, H. Schmidhammer, C. Smith, 1989, Journal of medicinal chemistry.

Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.

J. Walker, C. Smith, J. Doxey, 1977, British journal of pharmacology.

Synthesis and biological evaluation of 14-alkoxymorphinans. 3. Extensive study on cyprodime-related compounds.

H. Schmidhammer, R. Krassnig, C. Smith, 1990, Journal of medicinal chemistry.

Dopamine agonist activity of 8-OH-DPAT.

C. Smith, S. Cutts, 1990, Archives internationales de pharmacodynamie et de therapie.

The anorectic properties of opiate antagonists

D. Sanger, C. Smith, C.F.C. Smith, 1984 .

Conformations and biological activities of cyclic analogues of choline aryl ethers.

E. R. Clark, C. Smith, 1971, British journal of pharmacology.

Alpha-adrenoreceptor reagents. 4. Resolution of some potent selective prejunctional alpha 2-adrenoreceptor antagonists.

A. Roach, C. Chapleo, M. Stillings, 1986, Journal of medicinal chemistry.

Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone.

R. Carling, R. Kobylecki, C. Smith, 1982, Journal of medicinal chemistry.

Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivatives.

A. Roach, I. McLay, A. Morley, 2000, Journal of medicinal chemistry.

Novel type of hydrogenator

P. Simmonds, C. Smith, 1972 .

Dicarbonylnitrosyl{Tris(3,5‐Dimethylpyrazolyl)Hydroborato}‐ Molybdenum(III) and Iodo‐, Alkoxy‐, and Alkylamido‐Molybdenum(III) Derivatives

J. L. Templeton, J. McCleverty, Christopher J. Jones, 2007 .

Opiate receptors in the rat vas deferens.

C. Smith, M. J. Rance, 1983, Life sciences.

Dopamine receptors in the mouse vas deferens.

P. Rowland, C. Smith, 1989, Archives internationales de pharmacodynamie et de therapie.

16-Me cyprenorphine (RX 8008M): a potent opioid antagonist with some delta selectivity.

C. Smith, 1987, Life Science.